Praveen P. Tipirneni - Jul 3, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
President and CEO, Director
Signature
/s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Stock symbol
MORF
Transactions as of
Jul 3, 2023
Transactions value $
-$189,639
Form type
4
Date filed
7/6/2023, 07:02 PM
Previous filing
Jun 14, 2023
Next filing
Aug 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $15.5K +3.6K +25.81% $4.32* 17.5K Jul 3, 2023 Direct
transaction MORF Common Stock Sale -$205K -3.6K -20.52% $57.04 13.9K Jul 3, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -3.6K -0.98% $0.00 365K Jul 3, 2023 Common Stock 3.6K $4.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.61 to $57.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option is fully vested.